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A three-dimensional culture of cortical tissues derived from pluripotent stem cells offers an
opportunity to model human brain development and disorders. In a recent issue of Nature,
Lancaster et al. describe a new method for generating cerebral organoids in a dish and use it to
model microcephaly.Just a little more than 6 years ago, it would
have seemed like science fiction to take
human skin cells and create parts of an
embryonic cortex. But today, thanks to
the tremendous progress in our ability
to manipulate cell identity, it is possible
to reprogram adult skin fibroblasts into
induced pluripotent stem cells (iPSCs)
(Takahashi et al., 2007) and coax them
into becoming a broad range of tissues.
Under the right conditions, PSCs have a
remarkable capacity to self-organize and
develop into recognizable three-dimen-
sional structures resembling miniature
organs, including the intestine, thyroid,
retina, or cortex (reviewed by Sasai,
2013; Figure 1). These in vitro prepara-
tions complement in vivo model organ-
isms and help to elucidate principles
of organ development and mechanisms
of genetic diseases.
The cerebral cortex is one of the most
intricate and complex organs in the
body. Its developmental origin, however,
stems from a single layer of neuroepithe-
lial progenitors that give rise to all the
other cell types in the cortex. Several lab-
oratories have demonstrated that PSCs
grown in vitro have an intrinsic tendency
to form polarized neuroepithelial struc-
tures with striking similarities to progeni-
tor zones of the embryonic cortex (Eiraku
et al., 2008; Gaspard et al., 2008; Mariani
et al., 2012). In a recent issue of Nature,
Lancaster et al. (2013) describe a method
for growing three-dimensional (3D) neural
tissue from human PSCs. They use this
method to model microcephaly—a devel-
opmental disorder characterized byseverely reduced brain size. Their
approach builds on previous methods
but incorporates new features, including
modified culture conditions and use of a
spinning bioreactor. The resulting cere-
bral organoids reach up to 4 mm in size
and contain more elaborate structures of
the human embryonic brain than what
has been shown previously.
Lancaster et al. (2013) initiate formation
of cerebral organoids in embryonic stem
(ES) cell medium with low levels of basic
fibroblast growth factor and then transfer
3D aggregates into neural induction
medium. In contrast to many current
directed neuronal differentiation proto-
cols, this method does not involve use of
the SMAD inhibitors that promote neuro-
ectoderm while suppressing mesoderm
and endoderm (Chambers et al., 2009).
These culture conditions are expected to
produce spontaneous differentiation into
neural as well as nonneural cell types.
Indeed, multiple regions within the orga-
noids lack neuronal identity based on
expression of general markers.
The spinning bioreactor is used to
improve nutrient absorption in growing or-
ganoids and enables formation of longer
continuous neuroepithelial-like zones,
instead of the smaller rosette structures
obtained with other protocols. Expanded
neuroepithelial regions consist of polar-
ized radial glia-like stem cells that sur-
round a fluid-filled cavity resembling the
lateral ventricle in the developing brain.
Because these cavities are fairly large,
the authors are able to use intraventricular
electroporation methods similar to what isCell 155, Sdone in mouse embryos in utero and
achieve specific labeling of the neural
stem cells. This is a useful approach for
characterizing the behavior of the founder
cells and their progeny, and it can be used
to genetically manipulate the cells.
In the developing forebrain, inhibitory
interneurons are born in the ventral parts
of the telencephalon and migrate tangen-
tially into the dorsal cortex. The same type
of migration between ventral and dorsal
regions appears to be recapitulated in a
subset of the cerebral organoids pro-
duced by Lancaster et al. Specifically,
there is a correlation between regions
with ventral forebrain identity and the
presence of Calretinin-expressing cells
oriented toward dorsal regions. Although
the evidence is indirect, as it is based on
a single time point and marker, it is an
example of how this model system can
be used in the future to study signaling
between different cell types within brain-
like tissues generated in a dish.
Despite the presence of multiple brain-
like regions, the authors acknowledge
that cerebral organoids do not fully
model the organization of the brain. For-
mation and juxtaposition of different re-
gions is random and lacks the overall
structure that develops in vivo. Moreover,
cortical lamination is incomplete, with
only two layer-specific neuronal sub-
types produced, suggesting that some
key developmental cues are missing.
This has been an ongoing challenge
for other aggregation-based methods,
although neurons of all six-layer identities
have been successfully generated usingeptember 26, 2013 ª2013 Elsevier Inc. 19
Figure 1. Generation of 3D Endodermal and Ectodermal Organoids from Skin Fibroblasts
Reprogramming of fibroblasts into induced pluripotent stem cells (iPSCs) enables in vitro differentiation
into tissue-specific progenitors, such as intestinal stem cells, thyroid, or neuroectodermal progenitors.
When grown under the right conditions in suspension, these progenitors self-organize into 3D tissues
resembling the intestine, thyroid, optic cup, or cerebral cortex.2D culture methods (Espuny-Camacho
et al., 2013).
Given that in-vitro-generated brain tis-
sues are still a simplified haphazard
approximation of their in vivo counter-
parts, what is the advantage of using
human stemcellmodels rather than in vivo
mouse models? One compelling argu-
ment will come from a clear demonstra-
tion that stem-cell-derived tissues reca-
pitulate distinguishing features of human
brain development. For example, unlike
mice, humans have an expanded outer
subventricular zone (oSVZ) made up of
neurogenic radial glia-like cells (oRGs)
and transit-amplifying cells that con-
tribute significantly to increased cortical
size and complexity (Hansen et al.,
2010). It has been shown that oRG cells
can be produced in vitro from human
PSCs (Shi et al., 2012). Importantly, Lan-
caster et al. (2013) extend these observa-
tions by showing that the oRGs reside in
oSVZ-like progenitor regions within the
cerebral organoids, much like they do
in vivo. In contrast, mouse ES cells differ-
entiated using a similar protocol fail to
generate oSVZ-like regions or oRGs. Pro-
vided that the generation of human-spe-
cific progenitor zones is a robust feature20 Cell 155, September 26, 2013 ª2013 Elseof this system, this model may serve as
a valuable in vitro platform for studying
the molecular mechanisms that regulate
human oRG development.
Another advantage of using human
iPSCs is the potential to gain new insight
into brain disorders in the most relevant
genetic context. For example, it is un-
known why mutations that lead to micro-
cephaly in people do not severely reduce
the size of a mouse brain. In their iPS
model of microcephaly, Lancaster et al.
(2013) identify a dramatic reduction in
the founder population of neuroepithelial
stem cells, coupled with premature
neuronal differentiation. Although this
phenotype is consistent with the prevail-
ing theories about microcephaly patho-
genesis based on mouse studies, the
mechanisms behind it are still uncertain.
It would be interesting to compare how
the same mutations will affect mouse
cerebral organoids in order to understand
the discrepancy between minor pheno-
types in mice and severe phenotypes in
humans.
In conclusion, with the growing number
of protocols for generating cortical neu-
rons in vitro, it is becoming clear that there
are multiple approaches to model humanvier Inc.cortical development. The protocol devel-
oped by Lancaster et al. (2013) provides
advantages over previous aggregation
methods, including favorable conditions
for the formation of an oSVZ-like progen-
itor zone. In addition, spontaneous co-
emergence of different brain-like regions
within a single organoid may yield an
in vitro platform for elucidating mecha-
nisms of brain patterning. Their work is
an important step toward development
of more refined protocols that will eventu-
ally achieve better organization of tissues
along the dorsal-ventral and anterior-pos-
terior axes. In time, the ability to create
more complete cerebral organoids in a
dish may come closer to reality. When
that happens, besides having the conve-
nience of in vitro models of brain develop-
ment and disease, there will be a whole
new set of ethical and philosophical
issues to contemplate.REFERENCES
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